CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss) Change in cumulative translation adjustment	Accumulated Other Comprehensive Income (Loss)	Equity of Non-controlling Interest	Change in cumulative translation adjustment	Total
Stockholders' equity, Beginning balance at Jan. 30, 2021	$ 130	$ 474,375	$ (447,455)					$ 27,050
Common Stock, Shares, Outstanding period beginning at Jan. 30, 2021	13,019,061
Net loss			(3,228)			$ (150)		(3,378)
Common stock issuances pursuant to equity compensation awards	$ 1	(262)						(261)
Common stock issuances pursuant to equity compensation awards (in shares)	76,341
Share-based payment compensation - options		668						668
Common stock and warrant issuance	$ 33	21,191						21,224
Common stock and warrant issuance (in shares)	3,289,000
Investment of non-controlling interest						3,430		3,430
Stockholders' equity, ending balance at May. 01, 2021	$ 164	495,972	(450,683)			3,280		48,733
Common Stock, Shares, Outstanding period end at May. 01, 2021	16,384,402
Stockholders' equity, Beginning balance at Jan. 29, 2022	$ 216	538,627	(469,463)		$ (2,428)	2,412		$ 69,363
Common Stock, Shares, Outstanding period beginning at Jan. 29, 2022	21,571,387							21,571,387
Net loss			(11,896)			(319)		$ (12,215)
Common stock issuances pursuant to equity compensation awards	$ 2	(212)						(210)
Common stock issuances pursuant to equity compensation awards (in shares)	232,630
Share-based payment compensation - options		985						985
Stockholders' equity, ending balance at Apr. 30, 2022	$ 218	$ 539,400	$ (481,359)	$ (4,275)	$ (6,703)	$ 2,093	$ (4,275)	$ 53,649
Common Stock, Shares, Outstanding period end at Apr. 30, 2022	21,804,017							21,804,017